Clients of Agmon with Tulchinsky Law Firm comment on the ‘excellent service’ they receive from ’great lawyers’. The firm prides itself on its expertise in licensing work, and its recent mandates include high-value deals for some of the country’s largest pharmaceutical companies; it is also adept in matters concerning R&D, regulatory compliance, M&A, IP commercialisation, VC funding, and healthcare litigation. Its clients range from innovative start-ups to multi-national companies. Lead partners Ehud Arad, Osnat Sarusi Firstater, and Uri Barak are recognised experts in corporate and investment matters for hi-tech and life sciences companies. Alon Tabak-Aviram is also recommended for advising leading companies in the pharmaceutical and biotech sectors on corporate and technology licensing matters.
Legal 500 redaktioneller Kommentar
- Profil
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Great team and lawyers.’
‘Excellent service.’
Kernmandanten
- Clalit Healthcare
- Livnat Poran
- Nuversys
- Past and current directors of Teva Pharmaceutical Industries Ltd.
- Shaare Zedek Scientific Ltd.
- Cantor Fitzgerald
- T- Syte
- Virtual Care
- Hospitech Respiration Ltd.
- Lifebiotic Medical research Ltd.
Highlight-Mandate
- Represented Teva in its license of a therapeutic antibody for atopic dermatitis and asthma from Biolojic Design, a biotech company that uses computational biology and artificial intelligence to transform antibodies into intelligent medicinal solutions.
- Represented Kamada, a global pharmaceutical company listed on NASDAQ and TASE, in its licensing and distribution agreements with several significant partners.
- Representing Biond Biologics, a private Israeli immunotherapy company, in several significant agreements that enhance its R&D capabilities, including an agreement with Janssen, valued at tens of millions of USD.
Anwält*innen
Praxisleitung
Ehud (Udi) Arad; Osnat Sarusi Firstater; Uri Barak
Weitere Kernanwält*innen
Alon Tabak-Aviram